Innovative use of antiviral therapy for Hepatitis C and drug policy initiatives made news this week in the ongoing fight against what has been called a silent killer. Quicker treatment times and lower costs means that the next generation of antiviral treatments for Hepatitis C will reach – and cure – more and more of the millions of people worldwide who suffer from the debilitating liver disease.
Hepatitis C: Six-Week Antiviral Therapy ‘Quick Cure’ And Price Agreement Bring Hope
Published by
Anya Wassenberg 